Industry News
After conquering the movie industry, Sir Peter Jackson is now focusing on the plant-based protein business.
23 October 2017
Industry News
Fonterra confident dairy will always trump synthetic alternatives
Fonterra Cooperative Group is confident the complexity of cow milk will always trump plant-based alternatives, which the Prime Minister’s chief science adviser Peter Gluckman sees as posing an “existential threat” to the country’s economic fortunes.
14 October 2017
Industry News
Synthetic foods to have ‘major impact’ within 10 to 15 years – Sir Peter Gluckman
New Zealand may need to reconsider its approach to genetically modified crops to respond to the economic threat presented by synthetic milk and meat, the Prime Minister’s chief science adviser, Sir Peter Gluckman, has suggested.
12 October 2017
Events
Entries closing soon for the Value of Medicines Award 2017
Only 2 weeks until entries close for the Value of Medicines Award 2017. The national award is open to any researchers, professors, clinicians, students or academics that have completed research in this area in the last 24 months.
26 September 2017
Industry News
Kiwi scientists to make Star Trek gadget a reality
A handheld gadget used to scan for diseases in the sci-fi series Star Trek could soon become reality, with a new Kiwi study targeting our high rates of skin cancer.
26 September 2017
Industry News
Impossible Foods opens new Oakland facility
Today marks the opening of Impossible Foods’ new East Oakland plant, meaning that the cult veggie burger that San Francisco diners have lined up to taste will soon make its way to hundreds of restaurants nationwide.
15 September 2017
Industry News
Merck Expands Celonic’s Upstream Capabilities with Mobius(R) Single-use Bioreactors
Merck, a leading science and technology company, today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of Merck’s Mobius(R) single-use bioreactors.
13 September 2017
Industry News
GapSummit, Washington DC, July 2017
GapSummit is Global Biotech Revolution’s (GBR) international and intergenerational leadership summit in biotechnology. Callaghan Innovation’s Max Thompson attended as one of 100 young leaders of tomorrow selected from 40+ countries to engage with more than 30 international speakers and leaders in the life sciences industry on the most pressing challenges and gaps in the bioeconomy.
13 September 2017
Industry News
Giving the future of healthcare a boost
Current healthcare trends would be witnessing more changes (or disruptions) as the impact of the Fourth Industrial Revolution (4IR) takes effect worldwide.
13 September 2017